Neo Citran Megfázásra És Köhögésre (Phenylephrine Hydrochloride, Guaifenesin, Paracetamol)

Phenylephrine hydrochloride, Guaifenesin and Paracetamol, the active ingredients in Neo Citran Megfázásra És Köhögésre, form a combination decongestant, expectorant, analgesic/antipyretic presented as an oral dosage form for oral use. The product is intended to relieve nasal congestion, productive cough and fever or headache associated with the common cold or influenza in adults and children. GNH USA supplies Neo Citran Megfázásra És Köhögésre as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. All batches are manufactured under EU GMP guidelines and undergo rigorous quality testing before release.

Neo Citran Megfázásra És Köhögésre is a combination oral product used to treat symptoms of upper respiratory tract infections such as the common cold and influenza. - Nasal congestion: reduces swelling of nasal mucosa, improving airflow and easing breathing difficulty. - Productive cough: thins and loosens airway mucus, facilitating expectoration and clearing of the respiratory tract. - Fever and headache: lowers elevated body temperature and alleviates pain associated with viral respiratory illnesses. - Sinus pressure: alleviates sinus discomfort by decongesting nasal passages and promoting drainage.

Like all medicines, Neo Citran Megfázásra És Köhögésre may cause unwanted reactions.

Common Side Effects: - Mild nausea or stomach upset. - Dizziness or light‑headedness. - Transient headache. - Dry mouth or throat irritation.

Serious or Rare Side Effects: - Severe allergic reaction (rash, itching, swelling, difficulty breathing). - Elevated liver enzymes or jaundice. - Significant blood pressure rise or hypertension.

Before using Neo Citran Megfázásra És Köhögésre, consider the following precautions. - Existing cardiovascular disease: monitor blood pressure as phenylephrine may increase it. - Liver impairment: use caution because paracetamol is metabolized hepatically. - Renal dysfunction: adjust use if kidney function is reduced, especially with guaifenesin. - Concurrent MAO‑inhibitors: avoid due to possible hypertensive reactions. - Pregnancy or breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Neo Citran Megfázásra És Köhögésre can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis when combined with phenylephrine. - Other paracetamol‑containing products: may cause hepatotoxicity from excess dosing. - Strong CYP2E1 inducers (e.g., carbamazepine): may increase paracetamol metabolism and reduce efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: phenylephrine may diminish their blood‑pressure‑lowering effect. - Diuretics: may enhance phenylephrine‑induced fluid retention. - Anticoagulants (warfarin): paracetamol can potentiate anticoagulant effect, requiring INR monitoring.